Sai Parenteral's IPO Allotment Status: Check on Bigshare, BSE, NSE

The Sai Parenteral's IPO allotment is expected on March 30, 2026. The IPO received a total subscription of 1.08x by the final day, with institutional investors and NII (non-institutional investors, meaning high-net-worth individuals) driving most of the demand. Retail participation stayed notably low throughout. This blog covers how to check your allotment status, what the subscription numbers mean, the latest GMP, and what to do next.

Important Dates

• Allotment Date: March 30, 2026
• Initiation of Refunds: April 1, 2026
• Credit of Shares to Demat: April 1, 2026
• Listing Date: April 2, 2026

How to Check Sai Parenteral's IPO Allotment Status?

Method 1: Check on BSE

• Go to: bseindia.com/investors/appli_check.aspx
• Select "Equity" as the issue type
• Choose "Sai Parenteral's" from the dropdown
• Enter your application number or PAN
• Click Submit to see your allotment status

Method 2: Check on NSE

• Visit: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Select "Sai Parenteral's IPO" from the list
• Choose your search mode: PAN, Application Number, or DPID/Client ID
• Enter the required details and click Submit

Method 3: Check on Bigshare (Registrar)

Bigshare Services is the official registrar for this IPO.

• Go to: https://www.bigshareonline.com/ipo_allotment.html
• Select "Sai Parenteral's" from the IPO list
• Choose your preferred search type: PAN, Application Number, or DP/Client ID
• Enter the details and click Submit

Sai Parenteral's IPO Subscription Details

Source: chittorgarh.com

• The IPO closed at just 1.08x overall, meaning it was subscribed barely above the minimum needed. Most demand came in on the last day, a pattern common in IPOs where investors wait to gauge interest before applying.
• NII demand at 2.45x was the strongest category, suggesting some high-net-worth investor confidence. QIB at 1.73x reflects moderate institutional interest.
• Retail response at 0.12x was unusually weak. This signals that small investors largely sat out, possibly due to the high valuation, negative cash flows, or lack of visible GMP excitement.

Sai Parenteral's IPO GMP Update

The grey market premium (GMP) for Sai Parenteral's IPO has remained at ₹0 throughout the subscription period and on allotment day, implying a 0% listing gain over the issue price of ₹392. The grey market is an unofficial, unregulated space where IPO shares are traded before listing. A flat GMP means informal traders are not pricing in any pop on listing day. Sentiment is neutral at best. This does not guarantee a flat or negative listing, but it is a signal worth noting.

Disclaimer: GMP is unofficial, unregulated, and can change rapidly. Do not make investment decisions based on GMP alone.

What’s Next After Allotment?

If shares are allotted:

• Your allotment status will be visible on BSE, NSE, or Bigshare by March 30, 2026
• Shares will be credited to your demat account by March 31, 2026
• If you received partial allotment (fewer lots than applied for), the remaining blocked amount will be unblocked automatically
• Watch the listing price on April 2, 2026 to decide whether to hold or exit

If shares are not allotted:

• Your blocked UPI or ASBA amount will be fully unblocked by March 31, 2026
• No manual action is needed for refunds; it happens automatically
• You can still buy the stock from the secondary market after listing on April 2
• Since the IPO was only marginally subscribed (1.08x total), chances of full allotment for retail applicants are relatively higher than in heavily oversubscribed IPOs

For detailed information, visit Sai Parenteral's official IPO page at INDmoney.

Final Word

Sai Parenteral's IPO closed with just 1.08x overall subscription and a flat GMP, reflecting cautious market sentiment rather than strong excitement. The business has genuine long-term potential through its CDMO growth and Noumed-linked export story, but today's valuation at 111.53x P/E leaves little room for near-term surprises. Check your allotment status on Bigshare or BSE on March 30, and if allotted, track the listing price closely before deciding your next move.

For more IPOs, check INDmoney’s IPO tracker here.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Please be informed that merely opening a trading and demat account will not guarantee investment in securities in the IPO. Investors are requested to do their own independent research and due diligence before investing in an IPO. Please read the SEBI-prescribed Combined Risk Disclosure Document prior to investing. This post is for general information and awareness purposes only and is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell, or subscribe for securities. INDstocks is acting as a distributor for non-broking products/services such as IPO, Mutual Fund, and Mutual Fund SIP. These are not exchange-traded products. All disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or the Arbitration mechanism. INDstocks Private Limited (formerly known as INDmoney Private Limited) does not provide any portfolio management services, nor is it an investment adviser. Logos above are the property of respective trademark owners, and by displaying them, INDstocks has no right, title, or interest in them. SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428.